ArnoldL, GadowKD, FarmerCA, FindlingRL, BuksteinO, MolinaBSG, BrownNV, LiX, Rundberg-RiveraEV, BangaloreS, PageK, HurtEA, RiceRJr, McNamaraNK, AmanMG: Comorbid anxiety and social avoidance in treatment of severe childhood aggression: Response to adding risperidone to stimulant and parent training; mediation of disruptive symptom response. J Child Adolesc Psychopharmacol, 25:203–212, 2015.
2.
FarmerC, ArnoldL, BuksteinO, FindlingR, GadowK, LiX, ButterE, AmanM: The Treatment of Severe Child Aggression (TOSCA) Study: Trial design challenges. Child Adolesc Psychiatry Mental Health, 5:1–11, 2011.
3.
FarmerC, BrownN, GadowK, ArnoldLE, KolkoDJ, FindlingR, MolinaB, Buchan-PageK, RiceR, BangaloreS, BuksteinO, Rundberg-RiveraV, McNamaraN, AmanM: Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol, 25:213–224, 2015.
4.
FindlingR, McNamaraN, BranickyL, SchluchterM, LemonE, BlumerJA: Double-blind pilot study of risperidone in the treatment of conduct disorder. J Amer Acad Child Adolesc Psychiatry, 39:509–516, 2000.
5.
Rundberg-RiveraEV, TownsendLD, SchneiderJ, FarmerCA, MolinaBS, FindlingRL, GadowKD, BuksteinOG, ArnoldLE, KolkoDJ, Buchan-PageKA, McNamaraNK, MichelC, AustinA, KippH, RiceRRJr, AmanMG: Participant satisfaction in a study of stimulant, parent training, and risperidone in children with severe physical aggression. J Child Adolesc Psychopharmacol, 25:225–233, 2015.
